Eli Lilly | LLY - Stock

Aktienkurs
916.48
Täglich Wechseln
-13.87 -1.49%
Monatlich
-10.20%
Jährlich
11.42%
Q1 Prognose
955.33




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Abbott USD 6.49B 220M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Baxter International USD 2.23B 228M 2025-12
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Coherus Biosciences USD 3.17M 1.12M 2025-12
Drreddys Laboratories INR 79.01B 3.41B 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
J&J USD 14.19B 45M 2025-12
Medtronic USD 6.16B 270M 2025-09
Merck USD 6.44B 157M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Novartis USD 6.42B 114M 2025-09
Novo Nordisk DKK 45.65B 21.26B 2025-06
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Phibro Animal Health USD 517.35M 45.57M 2025-12
Prestige Brands USD 163.59M 4.6M 2025-12
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Zoetis USD 2.43B 35M 2025-12